Djibouti vs Mali: Cause of death, by non-communicable diseases, ages 5-14, male
Djibouti
21.1%
in 2021
Mali
21.3%
in 2021
Djibouti rank
145th
Mali rank
144th
Cause of death, by non-communicable diseases, ages 5-14, male over time
- Djibouti
- Mali
How they compare
Mali currently reports 21.3% against 21.1% in Djibouti, a difference of 0.2%.
Across all 6 years both countries report, Mali has been ahead every year.
Djibouti ranks 145th and Mali ranks 144th of 185 countries.
Mali has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Djibouti | Mali | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 7.8% | 16.1% | 8.3% | Mali |
| 2010s | 18.9% | 20.4% | 1.4% | Mali |
| 2020s | 21.2% | 21.4% | 0.3% | Mali |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, male, Djibouti or Mali?
- Mali, at 21.3% against 21.1% in Djibouti as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, male between Djibouti and Mali?
- 0.2%, with Mali ahead.
- How many years of comparable data are there for Djibouti and Mali?
- 6 years are reported by both, from 2000 to 2021.
- How do Djibouti and Mali rank globally for cause of death, by non-communicable diseases, ages 5-14, male?
- Djibouti ranks 145th and Mali ranks 144th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.